Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Robert W. Ross"'
Raoultella ornithinolytica and Klebsiella oxytoca pyogenic liver abscess presenting as chronic cough
Publikováno v:
IDCases, Vol 20, Iss , Pp e00736- (2020)
Raoultella ornithinolytica is a Gram-negative rod belonging to the Enterobacteriaceae family and closely related to Klebsiella spp. It is commonly present in aquatic environments. Human infections caused by R. ornithinolytica are being increasingly r
Externí odkaz:
https://doaj.org/article/6cc1ff541d8f41188e2367a97c41ed28
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 9, Iss 12, Pp 1160-1165 (2007)
BACKGROUND: In this study, we report on the use of a new, bolus-injectable, carboxymethyl dextran-based magnetic nanoparticle (MNP), ferumoxytol, to improve detection in loco-regional lymph nodes by magnetic resonance imaging (MRI). Methods: This pre
Externí odkaz:
https://doaj.org/article/550dd590fcdd4dd992e75283b2ffe31a
Publikováno v:
Journal of Infection and Chemotherapy. 29:646-653
Publikováno v:
Open Forum Infectious Diseases. 9
Background Community acquired pneumonia(CAP) is one of the highest infectious causes of mortality. Recommendations about the use of blood cultures in the diagnosis and treatment of CAP has been a continuous topic of debate. Current guidelines specify
Autor:
Kapil R. Dandekar, Robert W. Ross, William M. Mongan, Adam K. Fontecchio, Ilhaan Rasheed, Patrick O’Neill, Genevieve Dion
Publikováno v:
COMPSAC
Proc COMPSAC
Proc COMPSAC
Currently, wired respiratory rate sensors tether patients to a location and can potentially obscure their body from medical staff. In addition, current wired respiratory rate sensors are either inaccurate or invasive. Spurred by these deficiencies, w
Autor:
Elisabeth I. Heath, Rana R. McKay, Susan F. Slovin, Christopher Sweeney, Mary-Ellen Taplin, Arif Hussain, Mark N. Stein, Philip W. Kantoff, Lillian Werner, Michael A. Carducci, Hai T. Tran, Amado J. Zurita, Justine Yang Bruce, Robert W. Ross
Publikováno v:
Journal of Clinical Oncology. 34:1913-1920
Purpose Patients with recurrent prostate cancer after local treatment make up a heterogeneous population for whom androgen deprivation therapy (ADT) is the usual treatment. The purpose of this randomized phase II trial was to investigate the efficacy
Autor:
Stany Chrétien, Jean-Sebastien Diana, Mariane de Montalembert, Olivier Hermine, Alexandria Petrusich, Janet L. Kwiatkowski, Catherine Poirot, Sandeep Soni, Christof von Kalle, Felipe Suarez, Laure Caccavelli, David Davidson, Olivier Negre, Thibaud Lefebvre, Emmanuel Payen, Elliott Vichinsky, David T. Teachey, Philippe Leboulch, Jean-Antoine Ribeil, Marina Cavazzana, Fabrice Monpoux, Suradej Hongeng, Gabor Istvan Veres, Mark C. Walters, John E.J. Rasko, Despina Moshous, Philippe Bourget, Michaela Semeraro, Stéphane Blanche, Salima Hacein-Bey-Abina, Alessandra Magnani, Chantal Brouzes, François Lefrère, Corinne Pondarré, Jean-François Meritet, P. Joy Ho, Laura Sandler, Robert W. Ross, Mohammed Asmal, Alexis A. Thompson, Morris Kletzel, Valentine Brousse, Yves Beuzard, Hervé Puy, Usanarat Anurathapan, Elisa Magrin, Gary J. Schiller
Publikováno v:
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2018, 378 (16), pp.1479-1493. ⟨10.1056/NEJMoa1705342⟩
The New England journal of medicine, vol 378, iss 16
New England Journal of Medicine, Massachusetts Medical Society, 2018, 378 (16), pp.1479-1493. ⟨10.1056/NEJMoa1705342⟩
The New England journal of medicine, vol 378, iss 16
International audience; BACKGROUND Donor availability and transplantation-related risks limit the broad use of allogeneic hematopoietic-cell transplantation in patients with transfusion-dependent beta-thalassemia. After previously establishing that l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89e6db8010bebd03bc12d4fc3bf6e82c
https://hal-cnrs.archives-ouvertes.fr/hal-03295931
https://hal-cnrs.archives-ouvertes.fr/hal-03295931
Autor:
Bénédicte Neven, Emmanuel Payen, Olivier Negre, Yves Beuzard, Mariane de Montalembert, Pablo Bartolucci, Laure Caccavelli, Thibaud Lefebvre, Robert W. Ross, Laura Sandler, Philippe Leboulch, Stany Chrétien, Michaela Semeraro, Sandeep Soni, Hervé Puy, Salima Hacein-Bey-Abina, Stéphane Blanche, Gabor Istvan Veres, Jean-Antoine Ribeil, Wassim El Nemer, David Grevent, Jean-François Meritet, Philippe Bourget, Alessandra Magnani, Marina Cavazzana, Elisa Magrin, Leslie Weber
Publikováno v:
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2017, 376 (9), pp.848-855. ⟨10.1056/NEJMoa1609677⟩
NEW ENGLAND JOURNAL OF MEDICINE
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Universidad de las Islas Baleares
New England Journal of Medicine, 2017, 376 (9), pp.848-855. ⟨10.1056/NEJMoa1609677⟩
New England Journal of Medicine, Massachusetts Medical Society, 2017, 376 (9), pp.848-855. ⟨10.1056/NEJMoa1609677⟩
NEW ENGLAND JOURNAL OF MEDICINE
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Universidad de las Islas Baleares
New England Journal of Medicine, 2017, 376 (9), pp.848-855. ⟨10.1056/NEJMoa1609677⟩
Sickle cell disease results from a homozygous missense mutation in the ß-globin gene that causes polymerization of hemoglobin S. Gene therapy for patients with this disorder is complicated by the complex cellular abnormalities and challenges in achi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ee6a056a57a254d6647a300aac19bf8
https://www.hal.inserm.fr/inserm-01834781/document
https://www.hal.inserm.fr/inserm-01834781/document
Autor:
Leah Katz, Sumit K. Subudhi, William Oh, Jay Magidson, Martin Fleisher, Howard I. Scher, Aseem Anand, Robert W. Ross, Matthew D. Galsky, Philip W. Kantoff, Karl Wassmann, Gwo-Shu Mary Lee
Publikováno v:
The Lancet Oncology. 13:1105-1113
Summary Background Survival for patients with castration-resistant prostate cancer is highly variable. We assessed the effectiveness of a whole-blood RNA transcript-based model as a prognostic biomarker in castration-resistant prostate cancer. Method
Autor:
David I. Quinn, Robert W. Ross, William Y. Kim, Stephanie Morrissey, Mario A. Eisenberger, Mary-Ellen Taplin, Geoffrey Buckle, Christopher W. Ryan, Thomas E. Hutson, Guru Sonpavde, Ulka N. Vaishampayan, Jonathan E. Rosenberg, Philip W. Kantoff, Noah M. Hahn, Daniel P. Petrylak, Evan Y. Yu, Amir Mortazavi, Toni K. Choueiri, Glenn J. Bubley, Susanna Jacobus
Publikováno v:
Journal of Clinical Oncology. 30:507-512
Purpose Vandetanib is an oral once-daily tyrosine kinase inhibitor with activity against vascular endothelial growth factor receptor 2 and epidermal growth factor receptor. Vandetanib in combination with docetaxel was assessed in patients with advanc